chr6-97179533-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001350599.2(MMS22L):c.2411C>T(p.Ser804Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000286 in 1,609,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001350599.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MMS22L | NM_001350599.2 | c.2411C>T | p.Ser804Leu | missense_variant | 17/25 | ENST00000683635.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MMS22L | ENST00000683635.1 | c.2411C>T | p.Ser804Leu | missense_variant | 17/25 | NM_001350599.2 | P1 | ||
MMS22L | ENST00000275053.8 | c.2411C>T | p.Ser804Leu | missense_variant | 17/25 | 2 | P1 | ||
MMS22L | ENST00000369251.6 | c.2291C>T | p.Ser764Leu | missense_variant | 15/23 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000109 AC: 27AN: 247274Hom.: 0 AF XY: 0.0000748 AC XY: 10AN XY: 133618
GnomAD4 exome AF: 0.0000254 AC: 37AN: 1457628Hom.: 0 Cov.: 30 AF XY: 0.0000207 AC XY: 15AN XY: 724914
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.2411C>T (p.S804L) alteration is located in exon 17 (coding exon 16) of the MMS22L gene. This alteration results from a C to T substitution at nucleotide position 2411, causing the serine (S) at amino acid position 804 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at